Novel mutations in penicillin-binding protein genes in clinical Staphylococcus aureus isolates that are methicillin resistant on susceptibility testing, but lack the mec gene

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 3, 2014, Pages 594-597

  Ba, Xiaoliang ^a   Harrison, Ewan M ^a   Edwards, Giles F ^b   Holden, Matthew T G ^c   Larsen, Anders Rhod ^d   Petersen, Andreas ^d   Skov, Robert L ^d   Peacock, Sharon J ^c,e   Parkhill, Julian ^c   Paterson, Gavin K ^a   Holmes, Mark A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b STOBHILL HOSPITAL   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d STATENS SERUM INSTITUT   (Denmark)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

lactams; mecA; mecC; MRSA

Indexed keywords

BACTERIAL DNA; MUTANT PROTEIN; PENICILLIN BINDING PROTEIN;

BACTERIAL GENOME; CHEMISTRY; DNA SEQUENCE; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PENICILLIN RESISTANCE; STAPHYLOCOCCUS INFECTION;

DNA, BACTERIAL; GENOME, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MUTANT PROTEINS; PENICILLIN-BINDING PROTEINS; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS;

EID: 84894079568     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt418     Document Type: Article

References (20)

1. Jevons MP. 'Celbenin'-resistant staphylococci. BMJ 1961; 1: 124-5.
2. Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with b-lactam resistance in Staphylococcus aureus. J Bacteriol 1984; 158: 513-6.
3. FudaC, SuvorovM,VakulenkoSBet al. Thebasis for resistance tob-lactam antibiotics by penicillin-binding protein 2a ofmethicillin-resistant Staphylococcus aureus. J Biol Chem2004; 279: 40802-6.
4. Garcia-Alvarez L, Holden MT, Lindsay H et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis 2011; 11: 595-603.
5. Tomasz A, Drugeon HB, de Lencastre HM et al. New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity. Antimicrob Agents Chemother 1989; 33: 1869-74.
6. McDougal LK, Thornsberry C. The role of b-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol 1986; 23: 832-9.
7. Gal Z, Kovacs P, Hernadi F et al. Investigation of oxacillin-hydrolyzing b-lactamase in borderline methicillin-resistant clinical isolates of Staphylococcus aureus. Chemotherapy 2001; 47: 233-8.
8. Hackbarth CJ, Kocagoz T, Kocagoz S et al. Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance. Antimicrob Agents Chemother 1995; 39: 103-6.
9. Nadarajah J, Lee MJ, Louie L et al. Identification of different clonal complexes and diverse amino acid substitutions in penicillin-binding protein 2 (PBP2) associated with borderline oxacillin resistance in Canadian Staphylococcus aureus isolates. J Med Microbiol 2006; 55: 1675-83.
10. Banerjee R, Gretes M, Harlem C et al. A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level b-lactam resistance contains mutations in three genes. Antimicrob Agents Chemother 2010; 54: 4900-2.
11. Griffiths JM, O'Neill AJ. Loss of function of the GdpP protein leads to joint b-lactam/glycopeptide tolerance in Staphylococcus aureus. Antimicrob Agents Chemother 2012; 56: 579-81.
12. Petersson AC, Eliasson I, Kamme C et al. Evaluation of four qualitative methods for detection of b-lactamase production in Staphylococcus and Micrococcus species. Eur J Clin Microbiol Infect Dis 1989; 8: 962-7.
13. Harrison EM, Paterson GK, HoldenMTGet al. Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC. EMBO Mol Med 2013; 5: 509-15.
14. Voladri RK, Kernodle DS. Characterization of a chromosomal gene encoding type B b-lactamase in phage group II isolates of Staphylococcus aureus. Antimicrob Agents Chemother 1998; 42: 3163-8.
15. Leski TA, Tomasz A. Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. J Bacteriol 2005; 187: 1815-24.
16. Gohring N, Fedtke I, Xia G et al. New role of the disulfide stress effector YjbH in b-lactam susceptibility of Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55: 5452-8.
17. Chambers HF, Sachdeva MJ, Hackbarth CJ. Kinetics of penicillin binding to penicillin-binding proteins of Staphylococcus aureus. Biochem J 1994; 301: 139-44.
18. Chambers HF, Sachdeva M. Binding of b-lactam antibiotics to penicillinbinding proteins in methicillin-resistant Staphylococcus aureus. J Infect Dis 1990; 161: 1170-6.
19. Kotsakis SD, Tzouvelekis LS, Zerva L et al. Staphylococcus lugdunensis strain with a modified PBP1A/1B expressing resistance to b-lactams. Eur J Clin Microbiol Infect Dis 2012; 31: 169-72.
20. Bobba S, Ponnaluri VK, MukherjiMet al. Microtiter plate-based assay for inhibitors of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55: 2783-7.